BioVie Stock Analysis

BIVI -  USA Stock  

USD 16.97  0.12  0.70%

The small drop in market price for the last few months could raise concerns from stockholders as the firm it trading at a share price of 16.97 on 16,715 in volume. The company executives did not add much value to BioVie investors in May. However, diversifying your holdings with BioVie Inc or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 9.0. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the BioVie partners.
Continue to Trending Equities.

Search Stock Analysis 

The BioVie stock analysis report makes it easy to digest most publicly released information about BioVie and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. BioVie stock analysis module also helps to analyze the BioVie price relationship with some important fundamental indicators such as market cap and management efficiency.

BioVie Stock Analysis Notes

About 82.0% of the company shares are held by company insiders. The company recorded a loss per share of 9.08. BioVie Inc had not issued any dividends in recent years. The entity had 1-125 split on the 22nd of November 2019. BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. BioVie Inc. was founded in 2013 and is based in Santa Monica, California. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people. For more info on BioVie Inc please contact Terren Peizer at 312 283 5793 or go to

BioVie Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. BioVie's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding BioVie Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
BioVie Inc generates negative expected return over the last 90 days
BioVie Inc has high historical volatility and very poor performance
BioVie Inc has high likelihood to experience some financial distress in the next 2 years
BioVie Inc was previously known as Biovie Inc and was traded on NASDAQ Exchange under the symbol NNAB.
Net Loss for the year was (68.84 M).
BioVie Inc currently holds about 11.88 M in cash with (3.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85.
BioVie Inc has a frail financial position based on the latest SEC disclosures
Roughly 82.0% of the company shares are held by company insiders
Latest headline from BioVie Inc falls -0.2680 percent for June 10 -

BioVie Largest EPS Surprises

Earnings surprises can significantly impact BioVie's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

BioVie SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. BioVie prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that BioVie investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial BioVie Inc specific information freely available to individual and institutional investors to make a timely investment decision.
11th of June 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets. Entry into a Material Definitive Agreement
17th of May 2021
Financial Statements and Exhibits. Regulation FD Disclosure
10th of May 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Unclassified Corporate Event. Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
29th of April 2021
Financial Statements and Exhibits. Regulation FD Disclosure
27th of April 2021
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
23rd of September 2020
Financial Statements and Exhibits. Unclassified Corporate Event. Unregistered Sales of Equity Securities

BioVie Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as BioVie is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioVie Inc backward and forwards among themselves. BioVie's institutional investor refers to the entity that pools money to purchase BioVie's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ameriprise Financial IncCommon Shares90.9 K1.8 M
Swisspartners LtdCommon Shares54.3 K1.1 M
Vanguard Group IncCommon Shares26.6 K514 K
Millennium Management LlcCommon Shares23.1 K447 K
Geode Capital Management LlcCommon Shares21.2 K410 K
Sowell Financial Services LlcCommon SharesK26 K
Citigroup IncCommon Shares457K
Note, although BioVie's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BioVie Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 250.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioVie's market, we take the total number of its shares issued and multiply it by BioVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

BioVie Profitablity

BioVie's profitability indicators refer to fundamental financial ratios that showcase BioVie's ability to generate income relative to its revenue or operating costs. If, let's say, BioVie is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, BioVie's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of BioVie's profitability requires more research than a typical breakdown of BioVie's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(13.02) (13.36) 
Return on Average Equity 4.49  4.84 
Return on Invested Capital 1.35  1.39 

Management Efficiency

The entity has return on total asset (ROA) of (37.39) % which means that it has lost $37.39 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (276.41) %, meaning that it created substantial loss on money invested by shareholders. BioVie management efficiency ratios could be used to measure how well biovie inc manages its routine affairs as well as how well it operates its assets and liabilities. BioVie Return on Average Equity is most likely to increase in the upcoming years. The last year's value of Return on Average Equity was reported at 4.49. The current Return on Invested Capital is estimated to increase to 1.39, while Return on Average Assets are projected to decrease to (13.36) . BioVie Tangible Assets Book Value per Share are most likely to slightly decrease in the upcoming years. The last year's value of Tangible Assets Book Value per Share was reported at 0.08
Last ReportedProjected for 2021
Book Value per Share(3.92) (4.03) 
Tangible Assets Book Value per Share 0.08  0.08 
Tangible Asset Value474.9 K404.7 K

Technical Drivers

As of the 17th of June 2021, BioVie shows the Mean Deviation of 6.41, risk adjusted performance of 0.0119, and Downside Deviation of 7.19. BioVie Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for BioVie Inc, which can be compared to its rivals. Please confirm BioVie Inc coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if BioVie Inc is priced correctly, providing market reflects its regular price of 16.97 per share. Given that BioVie has jensen alpha of 0.1326, we suggest you to validate BioVie Inc's prevailing market performance to make sure the company can sustain itself at a future point.

BioVie Inc Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of BioVie Inc more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

BioVie Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioVie insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioVie's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BioVie insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

BioVie Predictive Daily Indicators

BioVie intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioVie stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

BioVie Forecast Models

BioVie time-series forecasting models is one of many BioVie's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioVie's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About BioVie Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how BioVie stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioVie shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as BioVie. By using and applying BioVie Stock analysis, traders can create a robust methodology for identifying BioVie entry and exit points for their positions.
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. BioVie Inc. was founded in 2013 and is based in Santa Monica, California. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.

Current BioVie Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BioVie analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BioVie analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
50.0Strong Buy1Odds
BioVie Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most BioVie analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioVie stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioVie Inc, talking to its executives and customers, or listening to BioVie conference calls.
BioVie Analyst Advice Details

BioVie Stock Analysis Indicators

BioVie Inc stock analysis indicators help investors evaluate how BioVie stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BioVie shares will generate the highest return on investment. By understating and applying BioVie stock analysis, traders can identify BioVie position entry and exit signals to maximize returns.
Quick Ratio36.83
Fifty Two Week Low7.50
Shares Short Prior Month176.69k
Average Daily Volume Last 10 Day61.16k
Average Daily Volume In Three Month80.34k
Shares Percent Shares Out1.38%
Short Percent Of Float2.03%
Forward Price Earnings-3.50
Float Shares2.51M
Fifty Two Week High46.10
Enterprise Value To Ebitda-50.85
Fifty Day Average15.21
Two Hundred Day Average20.67
Continue to Trending Equities. Note that the BioVie Inc information on this page should be used as a complementary analysis to other BioVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for BioVie Stock analysis

When running BioVie Inc stock analysis, check to measure BioVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioVie is operating at the current time. Most of BioVie's stock examination focuses on studying past and present price action to predict the probability of BioVie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BioVie's price. Additionally, you may evaluate how the addition of BioVie to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
The market value of BioVie Inc is measured differently than its book value, which is the value of BioVie that is recorded on the company's balance sheet. Investors also form their own opinion of BioVie stock's value that differs from its market value or its book value, called intrinsic value, which is BioVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioVie's market value can be influenced by many factors that don't directly affect BioVie Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioVie's stock value and its price as these two are different measures arrived at by different means. Investors typically determine BioVie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioVie's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.